Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt) is a transcription factor and a member of the nuclear receptor family, encoded by the RORC gene. It is an isoform of RORγ, primarily expressed in immune cells, especially T helper 17 (Th17) cells and certain innate lymphoid cells (ILC3s). It is essential for thymocyte survival during T cell development and acts as a master regulator for Th17 lineage specification, inducing the expression of signature cytokines such as IL-17A and IL-17F. RORγt is a central driver of autoimmune pathologies mediated by pathogenic Th17 responses and is considered an attractive drug target for autoimmune and inflammatory conditions.
RORγt inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt).